The endemic paraganglioma syndrome type 1: Origin, spread, and clinical expression

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages

  Schiavi, Francesca ^a   Demattè, Serena ^b   Cecchini, Maria Enrica ^b   Taschin, Elisa ^a   Bobisse, Sara ^a   Del Piano, Antonella ^b   Donner, Davide ^b   Barbareschi, Mattia ^b   Manera, Vittorio ^c   Zovato, Stefania ^a   Erlic, Zoran ^d   Savvoukidis, Theodoros ^e   Barollo, Susi ^f,k   Grego, Franco ^k   Trabalzini, Franco ^g   Amistà, Pietro ^h   Grandi, Cesare ^b   Branz, Fabio ^b   Marroni, Fabio ⁱ   Neumann, Hartmut P H ^j   Opocher, Giuseppe ^a,k   more..

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b Operative unit of Otolaryngology   (Italy)

^c Cles Hospital   (Italy)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^f UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^g UNIVERSITY HOSPITAL OF SIENA   (Italy)

^h Rovigo City Hospital   (Italy)

ⁱ Institute of Applied Genomics   (Italy)

^j UNIVERSITY OF FREIBURG   (Germany)

^k UNIVERSITY OF PADOVA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYSTEINE; GUANINE; TYROSINE;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CULTURAL FACTOR; DISEASE TRANSMISSION; ENDEMIC DISEASE; GENE ISOLATION; GENETIC RISK; GENETIC SCREENING; GENOTYPE; GEOGRAPHY; HEAD AND NECK CANCER; HEAD AND NECK PARAGANGLIOMA; HUMAN; MUTATIONAL ANALYSIS; PARAGANGLIOMA; PARAGANGLIOMA SYNDROME TYPE 1; PENETRANCE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SDHF GENE; TUMOR GENE;

AGE OF ONSET; AMINO ACID SUBSTITUTION; ENDEMIC DISEASES; FEMALE; FOUNDER EFFECT; HEAD AND NECK NEOPLASMS; HUMANS; ITALY; MALE; MUTATION; PARAGANGLIOMA; PENETRANCE; PHENOTYPE; PREVALENCE; SUCCINATE DEHYDROGENASE;

EID: 84859534175     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2597     Document Type: Article

References (20)

1. Baysal BE 2008 Clinical and molecular progress in hereditary paraganglioma. J Med Genet 45:689-694
2. Baysal BE 2002 Hereditary paraganglioma targets diverse paraganglia. J Med Genet 39:617-622 (Pubitemid 35001714)
3. Fuochi C, Peterlongo P, Moser E, Dalla Palma F, Bolner A, Smiroldo G, Babighian G 1986 Chemodectomi familiari e non familiari del capo e del collo. Studio Clinico-radiologico di 24 pazienti. Riv Med Trentina 24:219-230
4. Valdagni R, Amichetti M 1990 Radiation therapy of carotid body tumors. Am J Clin Oncol 13:45-48 (Pubitemid 20114559)
5. Milunsky JM, Maher TA, Michels VV, Milunsky A 2001 Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 100:311-314 (Pubitemid 32382404)
6. Marroni F, Cipollini G, Peissel B, D'Andrea E, Pensabene M, Radice P, Caligo MA, Presciuttini S, Bevilacqua G 2008 Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis. Ann Hum Genet 72:310-318 (Pubitemid 351524195)
7. Oosterwijk JC, Jansen JC, van Schothorst EM, Oosterhof AW, Devilee P, Bakker E, Zoeteweij MW, van der Mey AG 1996 First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas). J Med Genet 33:379-383 (Pubitemid 26147869)
8. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C, European-American Paraganglioma Study Group 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA [Erratum (2004) 292: 1686] 292:943-951
9. Liapis CD, Bellos JK, Halapas A, Lembessis P, Koutsilieris M, Kostakis A 2005 Carotid body paraganglioma and SDHD mutation in a Greek family. Anticancer Res 25:2449-2452 (Pubitemid 41044730)
10. Braun S, Riemann K, Kupka S, Leistenschneider P, Sotlar K, Schmid H, Blin N 2005 Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas. Anticancer Res 25: 2809-2814 (Pubitemid 41044666)
11. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG 2006 Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 91:827-836 (Pubitemid 43357746)
12. Fish JH, Klein-Weigel P, Biebl M, Janecke A, Tauscher T, Fraedrich G 2007 Systematic screening and treatment evaluation of hereditary neck paragangliomas. Head Neck 29:864-873 (Pubitemid 350303675)
13. Opocher G, Schiavi F 2010 Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab 24:943-956
14. Pasini B, Stratakis CA 2009 SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 266:19-42
15. van Schothorst EM, Jansen JC, Grooters E, Prins DE, Wiersinga JJ, van der Mey AG, van Ommen GJ, Devilee P, Cornelisse CJ 1998 Founder effect at PGL1 in hereditary head and neck paraganglioma families from The Netherlands. Am J Hum Genet 63:468-473 (Pubitemid 30418628)
16. Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Bröcker-Vriends AH, van Der Mey AG, van Ommen GJ, Cornelisse CJ, Devilee P 2001 Nearly all hereditary paragangliomas in The Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 31:274-281 (Pubitemid 32521758)
17. Hensen EF, Jansen JC, Siemers MD, Oosterwijk JC, Vriends AH, Corssmit EP, Bayley JP, van der Mey AG, Cornelisse CJ, Devilee P 2010 The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family. Eur J Hum Genet 18:62-66
18. Hensen E, van Duinen N, Jansen J, Corssmit E, Tops C, Romijn J, Vriends A, van der Mey A, Cornelisse C, Devilee P, Bayley J 2012 High prevalence of founder mutations of the succinate dehydrogenase genes in The Netherlands. Clin Genet 81:284-288
19. Yeap PM, Tobias ES, Mavraki E, Fletcher A, Bradshaw N, Freel EM, Cooke A, Murday VA, Davidson HR, Perry CG, Lindsay RS 2011 Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect. J Clin Endocrinol Metab 96:E2009-E2013
20. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE 2003 Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum Genet 113:228-237 (Pubitemid 36992281)